Ginkgo Bioworks Holdings, Inc. reported on August 29, 2025, that it entered a settlement agreement on May 27, 2025, regarding stockholder derivative actions, which includes a $4.125 million payment, corporate governance reforms, and a dismissal of the lawsuits, pending court approval.